ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

No Cancer Letter For Two Weeks

August 10, 1990

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

DCE Board Approves Concept For 14-19 New Grants, Four New Contracts

November 4, 1988

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974